Colin Hislop's Net Worth

$458 Thousand

Estimate Recalculated Sep 8, 2024 07:20PM EST

Who is Colin Hislop?

Colin Hislop does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Versartis, Inc., and Anthera Pharmaceuticals Inc.

SEC CIK

Colin Hislop's CIK is 0001314902

Past Insider Trading and Trends

2017 was Colin Hislop's most active year for acquiring shares with 3 total transactions. Colin Hislop's most active month to acquire stocks was the month of December. 2017 was Colin Hislop's most active year for disposing of shares, totalling 3 transactions. Colin Hislop's most active month to dispose stocks was the month of March. 2017 saw Colin Hislop paying a total of $285,950.00 for 98,200 shares, this is the most they've acquired in one year. In 2017 Colin Hislop cashed out on 70,667 shares for a total of $743,700.85, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Versartis, Inc. (ARAV) No price found

Chief Medical Officer

Colin Hislop owns 23,833 units of Common Stock. In the year 2016 Colin Hislop filed a total of 6 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.72%
-667.00
$2.55
-$1,700.85
23.83K
Oct 19
Form 4
—
0
$14.68
-$456,050.00
24.5K
Scheduled
Apr 4
Form 4
+390.00%
19.5K
—
—
24.5K
Jan 27
Form 4
∞
5K
—
—
5K
Oct 11
Form 4
—
0
—
—
0
Apr 4
Form 3
—
0
—
—
0
No matching records found

Anthera Pharmaceuticals Inc No price found

Sr. VP, Cardiovasc. Prod.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found